Cross Country Healthcare (CCRN) Tops Q4 EPS by 10c, Offers Guidance

Cross Country Healthcare (NASDAQ: CCRN) reported Q4 EPS of $0.19, $0.10 better than the analyst estimate of $0.09. Revenue for the quarter came in at $215.6 million versus the consensus estimate of $196.42 million.

GUIDANCE:

Cross Country Healthcare sees Q1 2021 EPS of $0.32-$0.37, versus the consensus of $0.07. Cross Country Healthcare sees Q1 2021 revenue of $280-295 million, versus the consensus of $201 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters